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Abstract 
 A novel and effective synthesis of substituted acetamide via smiles rearrangement is described. Treatment of phenols 
with 2-chloroacetamide in the presence of sodium hydroxide and DMA where substituted phenols, which contain electron 
withdrawing groups, are more reactive for smiles rearrangement. The reaction followed by cyclization of the product by E.A.A. 
afforded the corresponding substituted phenanthrolinone and naphthyridinone in good yields and showed higher activity against  
(G
-
 and G
+
, Eschierchia coli and Staphylococcus aureus respectively) and good activity toward Aspergillius flavus and Candida 
albicans.  
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1. Introduction: 
Smiles rearrangement [1] is one of the most important nucleophilic aromatic substitution reaction which attributed in the 
recent years in the studying of organic heterocylic compounds and the derivatives of its especially pyridine derivatives [2-7] that 
has a wide application and more effectiveness in medicinal chemistry and biological activity.  
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Scheme (1): 
General smiles rearrangement 
Dihydropyridine drugs, especially nifedipine, nicardipine and amalodipine, shows significant cardiovascular effect in the 
treatment of hypertension [8]. But, even though these drugs can be utilized, the synthesis of these compounds requires 
expensive reagents, organic solvents, a long reaction times and the yield result is usually unsatisfactory. Consequently, there 
has been focused efforts on developing effective and functional method for the implementation of the Hantzsch reaction, and 
there are potential researches on improved reaction conditions, consuming less reaction times and affording satisfactory yields 
[9-11].  
Heterocyclic compounds exhibited highly biological activity as anti-bacteria, anti-fungel, anti-inflammatory, antipyretic 
and antihypertensive agents [12-17]. Here, in this work we synthesized phenanthrolinone and napthyridinone derivates by using 
either phenol or substituted phenol as starting materials which were transformed to amide derivatives and by treatment with 
E.A.A, the cyclization form took place to afford the substituted pyridinones. This protocol described one pot method proceeds via 
two-steps process through smiles rearrangement [18] to provide the desired products in good yields as in scheme (2). 
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Scheme (2): Alkylation-smiles rearrangement sequence  
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Proposal mechanism for scheme (2) 
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2. Results and Discussion  
2.1. Chemistry 
The synthetic route to prepare the different target compounds is described in scheme (3). Compound (1) and (2) 
afforded (9) and (10) via smiles rearrangement followed by cyclization with ethylacetoacetate to produce phenanthrolinone (11) 
and naphthyridinone (12) derivatives. Compound (3) and (4) also reacted to produce new compounds (7) and (8) but they failed 
to follow smiles rearrangement because they react with 2-chloroacetamide to produce the cyclized forms (benzofuranyl and 
isoquinolinone) (scheme 3) with expected biological activity similar to heterocyclic of medicinal properties and their effect on the 
blood pressure reduction in spontaneously hypertensive rats [19]; and their cardiotonic and renal vasodilating effects [20].  
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3. Biological activity:  
Disk diffusion method for filamentous fungi tested by using approved standard method (M38-A) developed by the 
NCCLS (2002) [21] for evaluating the susceptibilities of filamentous fungi to antifungal agents.  
Disk diffusion method for yeasts developed by using approved standard method (M44-P) by the NCCLS (2003) 
[22]. 
Standard discs of tetracycline (antibacterial agent), amphotericin B (antifungal agent) served as positive controls 
for antimicrobial activity but filter discs impregnated with 10 μl of solvent (distilled water, chloroform, DMSO) were used as 
a negative control.  
The agar used is Meuller-Hinton agar that is rigorously tested for composition and pH, further the depth of the 
agar in the plate is a factor to be considered in the disc diffusion method. This method is well documented and standard 
zones of inhibition have been determined for susceptible and resistant values.  
Blank paper disks (Schleicher and Schuell, Spain) with a diameter of 8.0 mm were impregnated 10 μl of tested 
concentration of the stock solutions. When a filter paper disc impregnated with a tested chemical is placed on agar the 
chemical will diffuse from the disc into the agar. This diffusion will place the chemical in the agar only around the disc. The 
solubility of the chemical and its molecular size will determine the size of the area of chemical infiltration around the dis . If 
an organism is placed on the agar it will not grow in the area around the disc if it is susceptible to the chemical. This area 
of no growth around the disc is known as a zone of inhibition or "clear zone".  
Agar-based methods such as Etest and disk diffusion can be good alternatives because they are simpler and 
faster than broth-based methods [23, 24]. 
From the results and regarding that fungi Aspergillus flavus and Candida albicans, most of the previous compounds 
were found inactive  against them except compound (5) which exhibited very higher activity towards them compared with that of 
standard drugs (tetracycline and amphotericin B), in addition compound (6) which showed higher activity towards Aspergillus 
flavus only. Also it is interesting to point at that the compounds (9), (11), (12) attributed to good activity against Escherichia 
coli and staphylococcus aurues.  
Compound No. 
Inhibition Zone Diameter (mm/mg sample) 
Af Ca Ec Sa 
S
ta
n
d
a
rd
 Tetracycline 
antibacterial agent  
– – 33 32 
Amphotericin B 
antifungal agent  
18 20 – – 
5 30 20 42 47 
6 13 0.0 0.0 0.0 
9 0.0 0.0 11 12 
11 0.0 0.0 13 15 
12 0.0 0.0 9 9 
Af - Aspergillus flavus, Ca - Candida albicans, Ec – Escherichia coli, Sa – Staphylococcus aureus  
 
4. Conclusion:  
 In summary we have developed a novel and efficient method for the synthesis of a wide range of phenanthrolinone and 
naphthyridinone derivatives via the sequential smiles rearrangement followed by intramolecular cyclization in good yields and 
exhibit antibacterial and antifungal agents. Further work including the application, chemical transformation and biological activity 
is underway in our laboratory.  
5. Experimental section:  
5.1. General  
Melting points were taken on Gallen kamp melting point apparatus and were uncorrected. Thin layer chromatography 
was performed with fluorescent silica gel plates HF254 (Merck), and plates were viewed under UV254 and 265 light. Infrared 
spectra (ν-cm
-1
) were recorded on Bruker vector Germany and on Mattson FT-IR 1000, using KBr disks, mass spectra were 
measured on GCO Finnigan MAT. 
1
H-NMR spectra were recorded on Gemini-300 MHZ for 
1
H and 100MHz for 
13
C respectively, 
in DMSO-d6 solution and TMS as internal standard in microanalytical center Cairo University - Egypt. Different phenols, 
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CH Cl
ethylacetoacetate and DMA were obtained from Fluka or Aldrich. The antibacterial activity was determined in microanalytical center 
Cairo University - Egypt.  
5.2. General procedure for compounds 5, 6, 9, 10, 11, 12 
 The phenol (1) or (2) (1 mmol), (1 mmol) of 2-chloroacetamide and (1 mmol) of sodium hydroxide in DMA (20 ml) 
were refluxed with stirring for 2 hrs to produce 2-aryloxyacetamide (5) or (6). Sodium hydroxide (2 mmol) was added to 
this solution and then the mixture was stirred at 50 C to produce N-aryl-2-hydroxy acetamide (9) or (10) which crystallized for 
each from ethyl alcohol and followed cyclized under the effect of ethylacetoacetate  (1 mmol) to produce the compounds (11) or 
(12) respectively which showed highest inhibition zone against Escherichia coli and staphylococcus aureus, then crystallized 
from ethyl alcohol.  
5.2.1. Compound 5: brown ppt (yield: 56%) m.p. 262
o
C. IR (KBr) (cm
-1
):  
:, 3352, 3185 (NH2), 3075 (CH, ar.), 2950 (CH2 aliphatic), 1676 (CO-NH2), 1559 (C=N); MS (m/z%): 202 (10.46%), 145 (100%); 
1
H-NMR, (DMSO-d6) δ: 4.32 (2H, CH2), 7.09 (2H, NH2), 7.41-8.50 (5H, ar. protons), 8.81 (CH, quinoline). 
5.2.2. Compound 6: white ppt (yield: 79%) m.p. 240
o
C. IR (KBr) (cm
-1
):  
ν: 3389-3220 (NH2), 3060 (CH, ar.), 2928 (CH2 aliphatic), 1648 (CO-NH2), 1560 (C=N); MS (m/z%): 152 (54.67%), 108 
(100%); 
1
H-NMR, (DMSO-d6) δ: 4.63 (2H, CH2), 6.05 (2H, NH2), 7.29-7.74 (3H, ar. protons), 8.59 (CH, pyridine). 
5.2.3. Compound 9: beige ppt (yield: 49%) m.p. 340
o
C. IR (KBr) (cm
-1
):  
ν: 3424 (OH), 3185 (NH), 3070 (CH, ar.), 2951 (CH2, aliphatic), 1666 (C=O), 1628 (C=N), MS (m/z%): 202 (81.48%), 203 
(M+1, 71.60%), 204 (M+2, 74.07%), 54 (100%), 
1
H, NMR, (DMSO-d6) δ: 1.96 (1H, OH), 4.69 (2H, metheline), 7.18 (1H, 
NH), 7.52-8.54 (5H, ar. protons), 8.82 (CH, quninoline). 
5.2.4. Compound 10: beige ppt (yield: 87%) m.p. decompose 260
o
C.  
IR (KBr) (cm
-1
): ν:3347 (OH), 3285 (NH), 3070 (CH, ar.), 2960 (CH2, aliphatic), 1654 (C=O) 1556 (C=N); MS (m/z%): 152 
(65.82%), 153 (M+1, 79.75%), 100 (100%); 
1
H-NMR (DMSO-d6) δ: 1.24(H, OH), 4.52 (2H,CH2), 6.05 (1H, NH), 7.42-7.48 (3H, 
Ar.), 7.51 (CH, pyridine). 
5.2.5. Compound 11: deep brown ppt (yield: 52%) m.p. 150
o
C. IR (KBr) (cm
-1
): ν: 3435 (NHstr.), 2981 (CH, ar.), 2935 (CH, 
CH3), 1725 (C=O), 1641 (NH, bend.) 1590 (C=N), 1409 (CH bend); MS (m/z%), 250 (52%), 124 (100%); 
1
-H-NMR, 
(DMSO-d6) δ: 1.72 (3H, CH3), 4.03 (1H, NH), 6.25 (1H, =CH-O), 7.25-7.36 (4H, ar.), 7.98 (CH, quninoline); 
13
C NMR (100 
MHZ, DMSO): δ 13.9, 100.4, 107.7, 110.1, 110.2, 110.4, 110.5, 124.5, 144.3, 158.6, 160.2, 168.8, 168.9, 170.7, 197.4. 
5.2.6. Compound 12: deep brown ppt (yield: 82%) m.p. 140
o
C. IR (KBr) (cm
-1
): ν: 3427 (NH), 2980 (CH, ar.), 2932 (CH, 
CH3), 1725 (C=O), 1641 (NH bend.), 1567 (C=N), 1431 (CH, bend.); MS (m/z%): 200 (30.22%), 108 (100%); 
1
H-NMR, 
(DMSO-d6) δ: 1.52 (3H, CH3), 4.09 (1H,NH), 6.01 (1H, =CH-O), 7.35-7.62 (2H, ar.), 9.97 (CH, pyridine); 
13
C NMR (100 
MHZ, DMSO): δ 17.7, 70.4, 71.1, 110.7, 123.5, 123.7, 123.9, 187.5, 188.6, 190.9, 208.7. 
5.3. General procedure for compounds 7, 8 
 The phenol (3) or (4) (1 mmol), (1 mmol) of 2-chloroactamide and (1 mmol) of sodium hydroxide in DMA (20 ml) were 
stirring for 2 hr to produce 4- (3-amino-1-benzofuran-5-yl) phenol (7) or 4-(chloroisoquinolin-3-(4H)-one) (8) which crystallized for 
each from ethyl alcohol. 
5.3.1. Compound 7: white ppt (yield: 88%) m.p. 305
o
C. IR (KBr) (cm
-1
):  
ν: 3599 (OH), 3465, 3417 (NH2), 3276-3168 (CH, ar.), 1599 (NH bend.); MS(m/z%): 225 (6.38%), 185 (100%); 
1
H-NMR, 
(DMSO-d6) δ: 4.44 (2H, NH2), 5.14 (1H, OH), 6.98-7.56 (7H, ar.); 
13
C NMR (100 MHZ, DMSO): δ 115.0, 115.5, 15.5, 
115.6, 117.8, 126.8, 127.1, 127.1, 127.2, 132.7, 156.9, 156.9, 167.8, 169.8. 
5.3.2. Compound 8: brown ppt (yield: 95%) m.p. above 350
o
C IR (KBr) (cm
-1
): ν: 3415 (OH due to keto-enol form), 2927 
(CH, ar.), 1675 (C=O), 1485 (C=N); MS (m/z%): 179 (2.69%), 121 (100%); 
1
H-NMR, (DMSO-d6) δ: 5.41 (1H,               ), 
7.20-7.74 (4H, ar.); 8.19 (1H, pyridine); 
13
C NMR (100 MHZ, DMSO): δ 61.2, 91.7, 113.7, 121.2, 127.8, 127.8, 130.7, 
164.6, 189.8.  
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